Inhibition of P-glycoprotein by natural products in human breast cancer cells

Archives of Pharmacal Research

Volumn 28, Issue 7, 2005, Pages 823-828

  Soo, Yeon Chung ^a   Min, Kyung Sung ^a   Na, Hyung Kim ^a   Jung, Ok Jang ^a   Eun, Jung Go ^a   Hwa, Jeong Lee ^a  

^a Ewha Womans University   (South Korea)

Author keywords

Daunomycin; MCF 7 ADR Cells; Natural Products; P glycoprotein

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; BIOCHANIN A; DAUNORUBICIN; FLAVONOID; GENISTEIN; GLYCOPROTEIN P; QUERCETIN; SILYMARIN;

ARTICLE; BREAST TUMOR; CELL SURVIVAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; DRUG RESISTANCE; HUMAN; IC 50; METABOLISM; MULTIDRUG RESISTANCE; TUMOR CELL LINE;

ANTIBIOTICS, ANTINEOPLASTIC; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; DAUNORUBICIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; FLAVONOIDS; GENISTEIN; HUMANS; INHIBITORY CONCENTRATION 50; P-GLYCOPROTEINS; QUERCETIN; SILYMARIN;

EID: 30544440659     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/BF02977349     Document Type: Article

References (28)

1. Ambudkar, S. V., Kimchi-Sarfaty, C., Sauna, Z. E., and Gottesman, M. M., P-glycoprotein: from genomics to mechanism. Oncogene, 22, 7468-85 (2003).
2. Chieli, E., Romiti, N., Cervelli, F., and Tongiani, R., Effects of flavonols on P-glycoprotein activity in cultured rat hepatocytes. Life Sci., 57, 1741-1751 (1995).
3. Conseil, G., Baubichon-Cortay, H., Dayan, G., Jault, J. M., Barron, D., and Di Pietro, A., Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein. Proc. Natl. Acad. Sci. U.S.A., 95, 9831-9836 (1998).
4. Critchfield, J. W., Welsh, C. J., Phang, J. M., and Yeh, G. C., Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells: activation of P-glycoprotein as a putative mechanisms. Biochem. Pharmacol., 48, 1437-1445 (1994).
5. Doige, C. A. and Ames, G. F., ATP-dependent transport systems in bacteria and humans: relevance to cystic fibrosis and multidrug resistance. Annu. Rev. Microbiol., 47, 291-319 (1993).
6. Duggan, J., Peterson, W. S., Schutz, M., Khuder, S., and Charkraborty, J., Use of complementary and alternative therapies in HIV-infected patients. AIDS Patient Care STDS, 15, 159-167 (2001).
7. Fardel, O., Lecureur, V., and Guillouzo, A., The P-glycoprotein multidrug transporter. Gen. Pharmac., 27, 1283-1291 (1996).
8. Ford, J. M. and Hait, W. N., Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol. Rev., 42, 155-199 (1990).
9. Gottesman, M. M. and Pasran, I., Biochemistry of multidrug resistance mediated by the multidrug transporter. Ann. Rev. Biochem., 62, 385-427 (1993).
10. Harker, G. and Sikic, B. I., Multidrug (Pleiotropic) Resistance in doxorubicin-selected variants of the human sarcoma cell line MES-SA. Cancer Res., 45, 4091-4096 (1985).
11. Higgins, C. F., ABC transporters: from microorganisms to man. Annu. Rev. Cell. Biol., 8, 67-113 (1992).
12. Horio, M., Gottesman, M. M., and Pastan, I., ATP-dependent transport of vinblastine in vesicles from human multi-drugresistant cells. Proc. Natl. Acad. Sci. U.S.A., 85, 3580-3584 (1988).
13. Ikegawa, T., Ohtani, H., Koyabu, N., Juichi, M., Iwase, Y., Ito, C., Furukawa, H., Naito, M., Tsuruo, T., and Sawada, Y., Inhibition of P-glycoprotein by flavonoid derivatives in adriamycin-resistant human myelogenous leukemia (K562/ADM) cell. Cancer Lett., 177, 89-93 (2002).
14. Juliano R. L. and Pastan I., A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta, 455, 152-162 (1976).
15. Kartner N., Riordan J. R., and Ling V., Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science, 221, 1285-1288 (1983).
16. Kasahara, K., Fujiwara, Y., Sugimoto, Y., Nishio, K., Tamura, T., Matsuda, T., and Saijo, N., Determinants of response to the DNA topoisomerase II inhibitors doxorubicin and etoposide in human lung cancer cell lines. J. Natl. Cancer Inst., 84, 113-118 (1992).
17. Kuhnau, J., The flavonoids. A class of semi-essential food components: their role in human nutrition. Wld. Rev. Nutr. Diet, 24, 117-191 (1976).
18. Ni, H., Simile, C., and Hardy, A. M., Utilization of complementary and alternative medicine by United States adults: results from the 1999 national health interview survey. Med. Care, 40, 353-358 (2002).
19. Phang, J. M., Poore, C. M., Lopaczynska, J., and Yeh, G. C., Flavol-stimulated efflux of 7,12-dimethylbenz(α)anthracene in multidrug-resistant breast cancer cells. Cancer Res., 53, 5977-5981 (1993).
20. Potter, J. D., Cancer prevention: epidemiology and experiment. Cancer Lett., 114, 7-9 (1997).
21. Raderer, M. and Scheitharuer, W., Clinical trials of agents that reverse multidrug resistance. A literature review. Cancer, 72, 3553-3563 (1993).
22. Scambia, G., Ranelleti, F. O., Panici, P. B., DiVincenzo, R., Bonanno, G., Ferrandina, G., Piantelli, M., Bussa, S., Rumi, C., Cianfriglia, M., and Mancuso, S., Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast cancer cell line: P-glycoprotein as a possible target. Cancer Chemother. Pharmacol., 34, 459-464 (1994).
23. Shikic, B. I., Modulation of multidrug resistance; at the threshold. J. Clin. Oncol., 11, 1629-1635 (1993).
24. Skehan, P., Storeng, R., Scudiero, D., Monks, A., McMahon, J., Vistica, D., Warren, J. T., Bokesch, H., Kenney, S., and Boyd, M. R., New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening. J. Natl. Cancer Inst., 82, 1107-1112 (1990).
25. Tsuruo, T., Iida, H., Tsukagoshi, S., and Sakurai, Y., Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res., 41, 1967-1972 (1981).
26. Wargovich, M. J., Experimental evidence for cancer preventive elements in foods. Cancer Lett., 114, 11-17 (1997).
27. Yahanda, A. M., Alder, K. M., Fisher, G. A., Brophy, N. A., Halseym, J., Hardy, R. I., Gosland, M. P., Lum, B. L., and Sikic, B. I., Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance. J. Clin. Oncol., 10, 1624-1634 (1992).
28. Zhang, S. and Morris, M. E., Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transport. J. Pharmacol. Exp. Ther., 304, 1258-1267 (2003).